A Sonosensitizing Nanoshuttle for Synergistic Hypoxia Relief and Immune Activation To Strengthen Sonodynamic Immunotherapy Against Triple-Negative Breast Cancer
ACS Nano · 13.01.2026 · 20 (1) · 1086-1102
DOI: 10.1021/acsnano.5c16697 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 30.12.2025. Verfasst von Shi-Man Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunotherapy, Ultrasonic Therapy, Nanoparticles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Department of Science and Technology of Hubei Province, Renmin Hospital of Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The therapeutic efficacy of ultrasound-based tumor therapy is greatly hampered by tumor hypoxia and an immunosuppressive microenvironment. To address this, a sonosensitizing nanoshuttle (DPPM@HA) was constructed by coencapsulating oxygen-carrying perfluocarbon (PFC) and the STING agonist DMXAA into PCN222-Mn metal-organic frameworks, followed by hyaluronic acid (HA) modification for tumor-targeted delivery. After systemic administration, DPPM@HA accumulated at tumor sites and was specifically internalized by tumor cells. Ultrasound (US) irradiation facilitated the liberation of oxygen from DPPM@HA to alleviate hypoxia and immune suppression, while adequate oxygen supply and the US-sensitization effects of Mn-TCPP in DPPM@HA jointly promoted the burst of cytotoxic reactive oxygen species (ROS), exacerbating US-induced tumor damage and eliciting severe immunogenic tumor cell death. Meanwhile, high-valence manganese in the frameworks consumed by glutathione and was reduced to Mn(II), facilitating the destruction of DPPM@HA to release the loaded DMXAA. The resultant Mn2+ synergized with DMXAA to provoke STING activation, intensifying downstream immune responses. Besides the suppression of the unilateral tumor by DPPM@HA-mediated sonodynamic immunotherapy, the synergy with immune checkpoint blockade further enhanced systemic antitumor immunity, achieving potent effects against distant tumors and metastases. Summarily, the proposed DPPM@HA-mediated sonodynamic immunotherapy offered a promising strategy for high-performance sonodynamic immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, P. R. China.
- Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China.
ORCID-Profile: Qing Zhou, Wei-Hai Chen, Xian-Zheng Zhang, Qing Deng
Förderung
- Department of Science and Technology of Hubei Province
- Renmin Hospital of Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, S. M., Gui, B., Liu, Q., Chen, H., Pu, H., Chen, Y., Zhou, Q., Chen, W. H., Zhang, X. Z., & Deng, Q. (2026). A Sonosensitizing Nanoshuttle for Synergistic Hypoxia Relief and Immune Activation To Strengthen Sonodynamic Immunotherapy Against Triple-Negative Breast Cancer. ACS Nano, 20(1), 1086-1102. https://doi.org/10.1021/acsnano.5c16697
Vancouver
Zhang SM, Gui B, Liu Q, Chen H, Pu H, Chen Y, et al. A Sonosensitizing Nanoshuttle for Synergistic Hypoxia Relief and Immune Activation To Strengthen Sonodynamic Immunotherapy Against Triple-Negative Breast Cancer. ACS Nano. 2026;20(1):1086-1102. doi:10.1021/acsnano.5c16697
BibTeX
@article{Zhang2026,
author = {Zhang, Shi-Man and Gui, Bin and Liu, Qianhui and Chen, Hong and Pu, Huan and Chen, Yueying and Zhou, Qing and Chen, Wei-Hai and Zhang, Xian-Zheng and Deng, Qing},
title = {A Sonosensitizing Nanoshuttle for Synergistic Hypoxia Relief and Immune Activation To Strengthen Sonodynamic Immunotherapy Against Triple-Negative Breast Cancer},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {1},
pages = {1086--1102},
doi = {10.1021/acsnano.5c16697}
}
EUVIMED